CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company developing breakthrough technology that overcomes drug resistance in solid tumors, announced that Deborah Moorad, MBA, is the company’s new chief executive officer. Moorad, who previously served as CEO of Nature Technology Corp., and is an Entrepreneur-in-Residence at Cortado Ventures, succeeds co-founder Eric Kmiec, Ph.D., who has been appointed […]
The post CorriXR Therapeutics Announces Deborah Moorad as New Chief Executive Officer appeared first on ChristianaCare News.
Related Posts:
This post was originally published on this site
Share this Post